Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
Epstein−Barr virus (EBV), a member of the <i>Herpesviridae</i> family, maintains a lifelong latent infection in human B cells. Switching from the latent to the lytic phase of its lifecycle allows the virus to replicate and spread. The viral lytic cycle is induced in infected cu...
Main Authors: | Abbie G. Anderson, Cullen B. Gaffy, Joshua R. Weseli, Kelly L. Gorres |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/11/5/450 |
Similar Items
-
Viral and host factors drive a type 1 Epstein–Barr virus spontaneous lytic phenotype
by: Katherine A. Willard, et al.
Published: (2023-12-01) -
Relationship between Epstein-Barr virus and cancer development
by: Medina-Ortega, Ángela Patricia, et al.
Published: (2017-04-01) -
Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses
by: Mike Dorothea, et al.
Published: (2023-04-01) -
Editorial: Epstein-Barr virus and its contribution to pediatric tumors
by: Paola Chabay, et al.
Published: (2022-09-01) -
Epstein-Barr virus reactivation in critically ill immunocompetent patients
by: Nicolas Libert, et al.
Published: (2015-02-01)